Drug Class Comparison Charts
211 - 225 of
367 Results
Sort Results:
Article:
Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for relapsing-remitting forms of multiple sclerosis (MS)
June 2014
Article:
Abilify Maintena (aripiprazole) will be another intramuscular long-acting atypical antipsychotic option
May 2014
Guideline:
Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache (2013)
November 2013
Article:
Intuniv XR (in-TOO-niv), a new once-daily extended-release guanfacine for ADHD in kids
November 2013